GARDASIL 20 ug/.5mL (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant INJECTION, SUSPENSION) 20 ug/.5mL

GARDASIL 20 ug/0.5mL is a recombinant vaccine designed to protect against certain strains of the human papillomavirus (HPV). This quadrivalent vaccine targets HPV types 6, 11, 16, and 18, which are associated with various health conditions. It is administered via intramuscular injection and is suitable for individuals seeking HPV prevention.

Strength

20 ug/.5mL

Pack Size

6 SYRINGE in 1 CARTON (0006-4109-09) / .5 mL in 1 SYRINGE (0006-4109-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GARDASIL 20 ug/0.5mL is primarily used for the prevention of diseases caused by human papillomavirus (HPV) types 6, 11, 16, and 18. This vaccine is often recommended for individuals who have not previously been vaccinated against these HPV strains. The vaccine is intended to help reduce the risk of certain health issues linked to HPV infection.

Side Effects

Common effects of GARDASIL 20 ug/0.5mL may include mild to moderate reactions at the injection site, such as pain, swelling, or redness. Some individuals might experience general symptoms like headache, fatigue, or mild fever following vaccination. These effects are typically temporary and resolve on their own.

Precautions & Warnings

GARDASIL 20 ug/0.5mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current health conditions or medications before receiving the vaccine.

Avoid Interactions

GARDASIL 20 ug/0.5mL may interact with certain medications or health conditions. It is advisable to discuss any current medications or health issues with a healthcare provider before receiving the vaccine. Specific interactions with other vaccines or medications should be evaluated by a healthcare professional.

Frequently Asked Questions

GARDASIL 20 ug/0.5mL is used to prevent diseases caused by human papillomavirus (HPV) types 6, 11, 16, and 18.

GARDASIL 20 ug/0.5mL is administered via intramuscular injection.

Common effects may include mild pain, swelling, or redness at the injection site, as well as general symptoms like headache or fatigue.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use.

It is important to discuss any current medications with a healthcare provider before receiving GARDASIL 20 ug/0.5mL.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.